Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Pomegranate Health vs Somi Health

Pomegranate Health
Graded #122

Higher grade

vs+0.7000000000000028
Somi Health
Graded #141

Lower grade

The verdict

Pomegranate Health takes it — 69.4/100 to 68.7/100, but only just.

Pomegranate Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pomegranate Health sells compounded semaglutide and tirzepatide with no membership and no consultation fee. Somi Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePomegranate Health +14
80
66
Dose & formulationSomi Health +11
64
75
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentSomi Health +11
65
76
Contract termsPomegranate Health +8
55
47
Pomegranate Health · left barSomi Health · right bar

The numbers

MetricPomegranate HealthSomi Health
WeighScore69.4/10068.7/100
GradeCC
Scorecard rank#122#141
Semaglutide$119/mo (starting price, compounded)$135/mo (starting dose, compounded)
Tirzepatide$149/mo (Starter tier, compounded)$165/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Pomegranate Health

Graded #122 · C

Strengths

  • No membership and no consultation fee — the site states 'No Membership required' and 'Transparent pricing, no hidden fees'
  • The semaglutide price sits in the product page's own static HTML, so it can be read before any intake
  • Shipping is included: 'shipped discreetly to your door at no extra cost'
  • Both semaglutide and tirzepatide are offered

Where it loses points

  • The tirzepatide price is not on the public site at all — it exists only inside the in-app pricing portal, and there is no standalone tirzepatide product page to read it from
  • Both published figures are floors, a 'Starts @' and a Starter tier, and no price is published for the dose you titrate up to
  • The states it can prescribe in are not disclosed anywhere; the dataset's own note records that semaglutide was unavailable in CA, IA and WI
  • Klarna, Afterpay and Affirm are offered at checkout, so any monthly figure seen in a financing widget is an instalment and not the medication price
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Somi Health

Graded #141 · C

Strengths

  • Among the lowest compounded prices: semaglutide $135/mo, tirzepatide $165/mo (3-month plan)
  • Oral semaglutide tablet option for those who want no injections
  • One price at any dose, with the medical visit and shipping included
  • LegitScript Approved seal displayed; partnered with 503A pharmacies
  • Free 2-5 day shipping; no insurance required

Where it loses points

  • Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
  • Homepage advertises a 100% money-back guarantee but Terms state all sales are final, no refunds on medication
  • Partner pharmacies are not individually named (material transparency gap)
  • No single prescribing medical group named; only affiliated professional entities
  • State availability not published; confirmed only during intake

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard